Dirk G. Brockstedt
Rapt Therapeutics (United States)(US)APT Therapeutics (United States)(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Listeria monocytogenes in Food Safety
Most-Cited Works
- → Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients(1999)1,114 cited
- → Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis(2016)714 cited
- → Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer(2015)588 cited
- → Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes(2004)444 cited
- → Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity(2006)391 cited
- → A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction(2011)364 cited